PositiveID Corporation
(Ticker: PSID)
The Front-Line in America's Home Defense
| |
PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry
PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. | |
Biological Detection and Diagnostics
PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.
| |
About M-BAND
"M-BAND continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins."
The technology was developed under contract with the U.S. Department of Homeland Security ("DHS") Science & Technology directorate, which included $30 million of contract funding, to detect an attack with a biological weapon.
| |
About Firefly
"PositiveID's Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results from a sample in less than 20 minutes"
Diagnostics at the point of need, compared to two to four hours for a lab device, using real-time TaqMan(R) PCR (polymerase chain reaction) chemistry. Firefly is being developed to meet the growing need for more rapid and accurate point-of-need diagnostics that will enable hospitals, first responders, and other providers to save lives.
| |
"The Company is Generating Revenue for the first time since its formation, and we have issued Revenue Guidance through the end of 2015 of $4-10 million (2014 and 2015 combined), $3.3 million of which is currently in backlog."
| |
PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
(GLOBE NEWSWIRE)
PositiveID Corporation ( PSID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies.
"There is a pervasive, global need for advanced biological detection capabilities, where time to detection is critical to stop a biological attack in its tracks," stated William J. Caragol, PositiveID's Chairman and CEO. "As evidenced by our current relationships with large commercial and government partners, we believe our M-BAND and Firefly Dx systems offer significant benefits over existing products, including faster, more accurate detection, at a lower cost. The Company is generating revenue for the first time since its formation, and we have issued revenue guidance through the end of 2015 of 4-10 million (2014 and 2015 combined), 3.3 million of which is currently in backlog."
A copy of the report is available on PositiveID's website at: globenewswire.com.
| |
"As more attention is being paid to the serious need for bio-threat detection technologies and programs, we continue to pursue opportunities with the U.S. government and other organizations to employ the critically important capabilities of our M-BAND and Firefly systems, which, we believe, offer accurate biological detection more rapidly than existing systems"
William J. Caragol~CEO
| |
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company") ( PSID), a developer of biological detection and diagnostics solutions, is now available.
The interview can be heard at:
globenewswire.com. | |
A Large Multi-Million Dollar Military Contract Would have a Huge Permanent Impact on the Share Price.
| |
| |
"We are proud of the goals we have achieved especially our intermediate goal of revenue generation. We look forward to building on our recent success and continuing to grow our revenue backlog."
| |
| |
